---
figid: PMC7906923__MED-41-961-g003
figtitle: Molecular signaling pathways implicated in neuroblastoma
organisms:
- Mus musculus
- Rattus norvegicus
- Gallus gallus
- Danio rerio
- Homo sapiens
- Saccharomyces cerevisiae
- Drosophila melanogaster
- NA
pmcid: PMC7906923
filename: MED-41-961-g003.jpg
figlink: pmc/articles/PMC7906923/figure/med21750-fig-0001/
number: F1
caption: Overview of the molecular signaling pathways implicated in neuroblastoma.
  The signaling pathways described to play a role in neuroblastoma cells are (1) PI3K/AKT/mTOR
  pathway—promotes NB cell survival and chemoresistance; (2) Wnt signaling, which
  is involved in drug resistance, stemness, and increases MYCN levels; (3) p53‐MDM2
  pathway, where MDM2 inhibits p53 activity, promotes angiogenesis, increases MYCN
  translation, and promotes drug resistance. Single nucleotide polymorphisms (i.e.,
  SNP309) and gene amplification increase MDM2 expression. In the p53‐MDM2 pathway,
  activated p53 is involved in apoptosis and growth arrest; (4) ALK signaling activates
  PI3K/AKT/mTOR, RAS‐MAPK, and MYCN expression, and an ALK(R1275Q) mutant inhibits
  the expression of BM‐ and ECM‐associated genes; (5) RAS‐MAPK signaling promotes
  the survival of neuroblastoma cells and is activated by EGFR signaling; (6) TrkB
  signaling activates the PIK/AKT/mTOR signaling; (7) MYCN signaling promotes NB cell
  proliferation and activates MDM2 expression. Gray boxes in the figure represent
  genetic aberrations (i.e., gene amplification, point mutations, translocations,
  and deletions) and promoter methylation, and yellow boxes represent downstream biological
  phenotypes (i.e., survival, chemoresistance, angiogenesis, apoptosis, cell cycle
  arrest, proliferation, and stemness) in neuroblastoma cells. AKT, protein kinase
  B; ALK, anaplastic lymphoma kinase; BDNF, brain‐derived neurotrophic factor; BM,
  basement membrane; ECM, extracellular matrix; EGFR, epidermal growth factor receptor;
  ERK, extracellular signal‐regulated kinase; FZD1, frizzled‐1; FZD6, Frizzled‐6;
  HBP1, HMG‐Box transcription factor 1; HIF, hypoxia‐inducible factor; MDR, multidrug
  resistance; MDM2, mouse double minute 2 homolog; MEK, mitogen‐activated protein;
  mTOR, mammalian target of rapamycin; NB, neuroblastoma; PI3K, phosphatidylinositol‐3‐kinase;
  RAS, rat sarcoma; TrKB, tropomyosin receptor kinase B; VEGF, vascular endothelial
  growth factor [Color figure can be viewed at wileyonlinelibrary.com]
papertitle: 'Molecular targeting therapies for neuroblastoma: Progress and challenges.'
reftext: Atif Zafar, et al. Med Res Rev. ;41(2):961-1021.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9628712
figid_alias: PMC7906923__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Gallus gallus
- Danio rerio
- Drosophila melanogaster
redirect_from: /figures/PMC7906923__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7906923__MED-41-961-g003.html
  '@type': Dataset
  description: Overview of the molecular signaling pathways implicated in neuroblastoma.
    The signaling pathways described to play a role in neuroblastoma cells are (1)
    PI3K/AKT/mTOR pathway—promotes NB cell survival and chemoresistance; (2) Wnt signaling,
    which is involved in drug resistance, stemness, and increases MYCN levels; (3)
    p53‐MDM2 pathway, where MDM2 inhibits p53 activity, promotes angiogenesis, increases
    MYCN translation, and promotes drug resistance. Single nucleotide polymorphisms
    (i.e., SNP309) and gene amplification increase MDM2 expression. In the p53‐MDM2
    pathway, activated p53 is involved in apoptosis and growth arrest; (4) ALK signaling
    activates PI3K/AKT/mTOR, RAS‐MAPK, and MYCN expression, and an ALK(R1275Q) mutant
    inhibits the expression of BM‐ and ECM‐associated genes; (5) RAS‐MAPK signaling
    promotes the survival of neuroblastoma cells and is activated by EGFR signaling;
    (6) TrkB signaling activates the PIK/AKT/mTOR signaling; (7) MYCN signaling promotes
    NB cell proliferation and activates MDM2 expression. Gray boxes in the figure
    represent genetic aberrations (i.e., gene amplification, point mutations, translocations,
    and deletions) and promoter methylation, and yellow boxes represent downstream
    biological phenotypes (i.e., survival, chemoresistance, angiogenesis, apoptosis,
    cell cycle arrest, proliferation, and stemness) in neuroblastoma cells. AKT, protein
    kinase B; ALK, anaplastic lymphoma kinase; BDNF, brain‐derived neurotrophic factor;
    BM, basement membrane; ECM, extracellular matrix; EGFR, epidermal growth factor
    receptor; ERK, extracellular signal‐regulated kinase; FZD1, frizzled‐1; FZD6,
    Frizzled‐6; HBP1, HMG‐Box transcription factor 1; HIF, hypoxia‐inducible factor;
    MDR, multidrug resistance; MDM2, mouse double minute 2 homolog; MEK, mitogen‐activated
    protein; mTOR, mammalian target of rapamycin; NB, neuroblastoma; PI3K, phosphatidylinositol‐3‐kinase;
    RAS, rat sarcoma; TrKB, tropomyosin receptor kinase B; VEGF, vascular endothelial
    growth factor [Color figure can be viewed at wileyonlinelibrary.com]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Alk
  - Bdnf
  - Fzd1
  - Fzd6
  - Ntrk2
  - Ctnnb1
  - Abcb1b
  - Mod2
  - ras
  - Hras
  - Kras
  - Rem1
  - pk
  - Zhx2
  - Hbp1
  - Mdk
  - Mtor
  - Cdkn2a
  - Ephb2
  - Mapk1
  - Mycn
  - Mdm2
  - Trp53
  - Hif1a
  - Vegfa
  - EGFR
  - ALK
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - BDNF
  - BDNF-AS
  - FZD1
  - FZD6
  - NTRK2
  - CTNNB1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - HBP1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - CDKN2A
  - EPHB2
  - MAPK1
  - MAPK3
  - MYCN
  - MDM2
  - TP53
  - TP63
  - TP73
  - HIF1A
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - Wnt2
  - Ephb1
  - Ccne1
  - Tp53
  - egfra
  - alk
  - ltk
  - bdnf
  - fzd1
  - fzd6
  - ctnnb1
  - tap2b
  - rab1ab
  - hbp1
  - mtor
  - mycn
  - mdm2
  - tp53
  - hif1ab
  - vegfaa
  - pnt
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Wnt5
  - Wnt4
  - wg
  - arm
  - Ras64B
  - Ras85D
  - Tnks
  - Raf
  - Dsor1
  - Mtk
  - Tor
  - Arl1
  - Arf1
  - Arl2
  - Erk7
  - rl
  - Bm
  - CycE
  - cyc
  - p53
  - betaTub60D
  - hth
  - sima
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - R1275Q
  - ARF
  - HIF-1a
---
